About SurModics
SurModics is a company based in Eden Prairie (United States) founded in 1979 was acquired by GTCR in May 2024.. The company has 389 employees as of September 30, 2024. SurModics has completed 2 acquisitions, including NorMedix and Vetex Medical. SurModics offers products and services including Pounce™ Thrombectomy System, Pounce™ Venous Thrombectomy System, Sublime™ Radial Access Platform, and Preside™ Hydrophilic Coatings. SurModics operates in a competitive market with competitors including Abingdon Health, Olink, US BioTek Laboratories, Spear Bio and Eclipse Bio, among others.
- Headquarter Eden Prairie, United States
- Employees 389 as on 30 Sep, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Surmodics, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of SurModics
SurModics is a publicly listed company on the NASDAQ with ticker symbol SRDX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of SurModics
SurModics offers a comprehensive portfolio of products and services, including Pounce™ Thrombectomy System, Pounce™ Venous Thrombectomy System, Sublime™ Radial Access Platform, and Preside™ Hydrophilic Coatings. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Device for rapid removal of peripheral arterial thrombi
System to capture and remove clots in peripheral veins
Tools for radial-to-peripheral procedures with kink resistance
Coatings for navigating tortuous anatomy in neuro and coronary areas
Unlock access to complete
Sales and Marketing
10 people
Software Development Team
9 people
Senior Team
6 people
Product Management Team
5 people
Principal Team
5 people
Operations Team
5 people
Leadership Team
4 people
Finance and Accounting
3 people
Unlock access to complete
Funding Insights of SurModics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SurModics
SurModics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include GTCR Chicago Private Equity Firm. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments and firm management in Chicago.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SurModics
SurModics has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include NorMedix and Vetex Medical. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Catheters for venous clot management and removal are developed.
|
2016 | ||||
|
Surgical medical devices are designed and developed by NorMedix.
|
2008 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - SurModics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Surmodics Comparisons
Competitors of SurModics
SurModics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abingdon Health, Olink, US BioTek Laboratories, Spear Bio and Eclipse Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of immunoassays for diagnostic purposes
|
|
| domain | founded_year | HQ Location |
Provider of products and services for human protein biomarker research and development
|
|
| domain | founded_year | HQ Location |
Provider of enzyme-linked immunosorbent assay technology services
|
|
| domain | founded_year | HQ Location |
Developer of ultrasensitive immunoassays and proteomics platforms for detecting protein biomarkers
|
|
| domain | founded_year | HQ Location |
Cell-free immunoassays are developed to identify RNA binding protein targets.
|
|
| domain | founded_year | HQ Location |
An in vitro assay platform is provided for diagnostic solutions.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Surmodics
Frequently Asked Questions about SurModics
When was SurModics founded?
SurModics was founded in 1979.
Where is SurModics located?
SurModics is headquartered in Eden Prairie, United States. It is registered at Eden Prairie, Minnesota, United States.
How many employees does SurModics have?
As of Sep 30, 2024, the latest employee count at SurModics is 389.
What is the annual revenue of SurModics?
Annual revenue of SurModics is $126.08M as on Sep 30, 2024.
What does SurModics do?
SurModics was founded in 1979 and is headquartered in Eden Prairie, United States. Operations focus on the biotechnology sector, where in-vitro diagnostic assays and reagents are produced for clinical applications. Immunoassays such as ELISAs are developed alongside point-of-care devices. Key products encompass antigens, antibodies, protein stabilizers, diluents, blockers, substrates, microarray slides, and TMB formulations to support diagnostic workflows.
Who are the top competitors of SurModics?
SurModics's top competitors include Abingdon Health, Eclipse Bio and Spear Bio.
What products or services does SurModics offer?
SurModics offers Pounce™ Thrombectomy System, Pounce™ Venous Thrombectomy System, Sublime™ Radial Access Platform, and Preside™ Hydrophilic Coatings.
Is SurModics publicly traded?
Yes, SurModics is publicly traded on NASDAQ under the ticker symbol SRDX.
How many acquisitions has SurModics made?
SurModics has made 2 acquisitions, including NorMedix, and Vetex Medical.
Who are SurModics's investors?
SurModics has 1 investor. Key investors include GTCR Chicago Private Equity Firm.
What is SurModics's ticker symbol?
The ticker symbol of SurModics is SRDX on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.